The FTO Gene and Weight Loss: Why Some Indians Struggle More (And What Helps)

"When a client has tried every dietary approach sincerely and nothing produces the expected result, genetics is one of the first places I look. The FTO variant is not destiny — but it is a meaningful headwind, and knowing about it changes the strategy." — Dt. Trishala Goswami, MSc Clinical Nutritionist, Certified Nutrigenomics Specialist

A client — let us call him Arjun — was 34, healthy, and had been trying to lose the same 8 kg for four years. He had tried low-calorie diets, intermittent fasting, and hired a personal trainer twice. He lost 2–3 kg on each attempt and invariably regained it within two months. His appetite was relentless — he described feeling genuinely hungry within 90 minutes of a full meal. His wife, eating the same food, had no such experience.

When Arjun's nutrigenomic profile was assessed, he carried two copies of the FTO rs9939609 risk variant — the homozygous form, associated with the most pronounced effect on appetite signalling and metabolic efficiency. His approach needed to be specifically designed around this biology, not around an average that assumed his hunger and satiety signals worked like everyone else's.

What Is the FTO Gene?

FTO stands for "Fat Mass and Obesity Associated" gene. Located on chromosome 16, it was the first gene identified in genome-wide association studies to have a significant association with body mass index and obesity risk in large populations. Since its discovery in 2007, it has been one of the most extensively studied genes in nutritional genomics.

The most clinically relevant variant is rs9939609 (A/T polymorphism):

• TT genotype: Low risk — the most common genotype in European populations
• AT genotype: Intermediate risk — carries one copy of the risk variant
• AA genotype: Highest risk — carries two copies of the risk variant (homozygous)

Why Are South Asians Disproportionately Affected?

The prevalence of the FTO risk variant (A allele) differs significantly across populations. Studies examining South Asian populations — including research published in journals including Nature Genetics, the American Journal of Human Genetics, and the Indian Journal of Endocrinology and Metabolism — have found the A allele frequency in South Asians to be notably higher than in European populations.

Additionally, South Asians develop visceral fat and insulin resistance at lower BMIs than European populations. The combination of higher FTO risk allele prevalence and greater metabolic susceptibility at lower body weights means the consequences of FTO-related fat storage tendencies may manifest earlier and more prominently in Indian populations.

This is one clinical explanation for why standard Western weight-loss advice — designed on the basis of predominantly European study populations — consistently underperforms when applied without modification to Indian individuals.

How Does the FTO Variant Actually Work?

For many years, FTO was thought to encode an enzyme that directly controlled fat metabolism. More recent research has revealed that the rs9939609 variant affects FTO primarily through its influence on two downstream transcription factors: IRX3 and IRX5 in adipocytes (fat cells). These regulate a process called thermogenesis — the conversion of energy to heat rather than to stored fat in brown and beige adipose tissue.

The risk variant is associated with reduced thermogenesis — the body is more metabolically efficient, converting less energy to heat and storing more as fat for the same caloric intake.

Additionally, FTO regulates ghrelin expression. Ghrelin is the primary hunger hormone — it rises before meals and falls after eating. People carrying the risk variant of FTO tend to have:

• Higher baseline ghrelin levels (more persistent hunger)
• Slower post-meal suppression of ghrelin (hunger returns sooner after eating)
• Blunted leptin sensitivity in some studies (weaker satiety signalling)

The practical result: FTO risk carriers experience genuine, physiologically real hunger more intensely and more frequently than non-carriers eating the same meals. This is not a willpower problem. It is a hormonal signal problem.

What the Evidence Suggests Helps FTO Risk Carriers

This is the most important section. Having the FTO risk variant is not deterministic — lifestyle factors have been consistently shown to meaningfully modify genetic risk.

Higher Protein Intake

Protein is the most potent macronutrient for suppressing ghrelin. High-protein meals produce a more sustained reduction in ghrelin compared to carbohydrate- or fat-matched meals. For FTO risk carriers whose ghrelin returns to hunger-level more quickly, ensuring adequate protein at every meal — not just total daily protein, but protein distributed across meals — is a first-line dietary strategy.

Indian food translation:

• Breakfast: Moong dal chilla, besan chilla, eggs, or high-protein dahi with nuts rather than plain poha or toast
• Lunch: Dal with adequate portions, paneer in sabzi, a glass of chaas
• Dinner: Adequately portioned dal or legume dish alongside vegetables — not just roti and sabzi without a protein source

Target: 1.2–1.6g protein per kg body weight per day, distributed across at least three meals.

Consistent Meal Timing

Regular meal timing prevents the large ghrelin spikes that occur with prolonged gaps between eating. For FTO carriers who are already prone to stronger hunger signals, skipping meals or leaving extended gaps creates a hunger environment that makes overeating at the next meal almost inevitable.

Structured three-meal eating — without prolonged gaps — is generally more effective for FTO carriers than intermittent fasting protocols that extend the fasting window, which can amplify ghrelin-driven hunger beyond a manageable threshold.

Aerobic Exercise — A Partial Genetic Offset

This is one of the most compelling findings in FTO research. A 2014 meta-analysis of over 218,000 participants published in PLoS Genetics found that physical activity significantly attenuated the association between FTO genotype and BMI — by approximately 30% in the most active individuals.

Aerobic exercise (brisk walking, cycling, swimming, dancing) appears to specifically modulate the FTO-related pathways involved in thermogenesis. This is not just "exercise helps weight loss" — it is a genotype-specific effect where FTO risk carriers who are physically active have substantially better outcomes than those who are sedentary, beyond the general calorie-burning effect of exercise.

For Indian lifestyles, brisk walking for 30–45 minutes at least 5 days per week remains the most accessible and sustainable form of aerobic exercise.

Adequate Sleep

As noted earlier in general weight management, sleep deprivation raises ghrelin and lowers leptin. For FTO carriers who already have a ghrelin dysregulation tendency, sleep deprivation compounds this effect. Prioritising 7–8 hours of sleep is particularly important for FTO risk carriers.

Lower Ultra-Processed Food Intake

Research specifically examining FTO carriers has found stronger associations between ultra-processed food consumption and BMI in FTO risk carriers than in non-carriers — suggesting the gene may amplify the adipogenic effect of these foods. Reducing ultra-processed foods (packaged snacks, biscuits, instant noodles, commercially fried foods) may have a proportionally greater benefit for FTO carriers than for non-carriers.

This Is Not Destiny

The largest GWA studies estimate that the homozygous AA FTO genotype accounts for approximately 3–5 kg difference in body weight compared to the TT genotype, in the absence of lifestyle interventions. When exercise and dietary quality are equivalent, this difference largely disappears.

The practical message: the FTO variant creates a meaningful biological headwind — stronger hunger, more efficient fat storage — but it does not override lifestyle. Understanding it changes the strategy (higher protein, aerobic exercise priority, structured meals, excellent sleep) rather than accepting a predetermined outcome.

For a comprehensive nutrigenomic assessment that maps your genetic variants to a personalised Indian dietary plan, see our Nutrigenomics programme. To understand the broader landscape of how DNA shapes dietary response, read our overview of nutrigenomics.

Frequently asked questions

Q: What is the FTO gene?

The FTO (Fat Mass and Obesity Associated) gene is a gene on chromosome 16 whose variants have been associated with body weight, appetite signalling, and metabolic efficiency in large population studies. The most studied variant, rs9939609, affects hunger hormone (ghrelin) regulation and thermogenesis (heat production vs fat storage) in fat cells. It is one of the most replicated genetic associations in obesity research.

Q: Does the FTO gene cause obesity?

The FTO risk variant does not cause obesity — it creates a biological tendency toward stronger hunger signals and more efficient fat storage that makes weight management more challenging. Carrying the risk variant is associated with approximately 3–5 kg greater body weight on average, in the absence of lifestyle interventions. Physical activity largely offsets this genetic risk. FTO is a predisposition, not a destiny.

Q: Can I lose weight if I have the FTO gene variant?

Yes. Research consistently shows that lifestyle factors — particularly aerobic exercise and high protein intake — significantly modify FTO-related risk. A 2014 meta-analysis of over 218,000 people found that physical activity attenuated the FTO-BMI association by approximately 30%. The strategy is different from a non-carrier (higher protein, consistent meal timing, exercise priority) but the outcome is not predetermined.

Q: How do I know if I have the FTO gene variant?

FTO genotyping is included in most comprehensive nutrigenomic DNA panels. Direct-to-consumer tests (23andMe, AncestryDNA) also report this variant, though interpretation should be done with a certified professional who can contextualise it alongside your full genetic profile, health history, and Indian dietary context. Testing alone without professional interpretation has limited actionability.

Q: What diet is best for FTO gene carriers?

Higher protein distribution across all meals (to blunt ghrelin), consistent meal timing without extended gaps, reduced ultra-processed food intake, and adequate sleep. Aerobic exercise is particularly impactful for FTO carriers — 30–45 minutes of brisk walking at least 5 days per week has been shown to significantly offset the genetic weight tendency. Indian food translation: prioritise dal, paneer, eggs, and dahi at every meal; eat structured three meals without skipping.